Neuroprotective activity of sub-anesthetic ketamine in a preclinical model of Parkinson’s disease is not blocked by antagonizing brain-derived neurotrophic factor signaling

Carolyn J. Stopera, Mitchell J. Bartlett, Kelsey Bernard, Rachel Conklin, Sansita Singh, Jennifer B. Frye, Lalitha Madhavan, Kristian R. Doyle, Scott J. Sherman, Kathy Steece-Collier, Torsten Falk

Open source

DOI
10.64898/2026.10.28.762430
Published
2026-10-29
Container
Not recorded
Publisher
openRxiv
Open access
unknown

Credibility signals

uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.64898/2026.10.28.762430,
  title = {Neuroprotective activity of sub-anesthetic ketamine in a preclinical model of Parkinson’s disease is not blocked by antagonizing brain-derived neurotrophic factor signaling},
  author = {Carolyn J. Stopera and Mitchell J. Bartlett and Kelsey Bernard and Rachel Conklin and Sansita Singh and Jennifer B. Frye and Lalitha Madhavan and Kristian R. Doyle and Scott J. Sherman and Kathy Steece-Collier and Torsten Falk},
  year = {2026},
  doi = {10.64898/2026.10.28.762430},
  url = {https://doi.org/10.64898/2026.10.28.762430}
}

RIS

TY  - JOUR
TI  - Neuroprotective activity of sub-anesthetic ketamine in a preclinical model of Parkinson’s disease is not blocked by antagonizing brain-derived neurotrophic factor signaling
AU  - Carolyn J. Stopera
AU  - Mitchell J. Bartlett
AU  - Kelsey Bernard
AU  - Rachel Conklin
AU  - Sansita Singh
AU  - Jennifer B. Frye
AU  - Lalitha Madhavan
AU  - Kristian R. Doyle
AU  - Scott J. Sherman
AU  - Kathy Steece-Collier
AU  - Torsten Falk
PY  - 2026
DO  - 10.64898/2026.10.28.762430
UR  - https://doi.org/10.64898/2026.10.28.762430
ER  - 

APA

Stopera, C. J., Bartlett, M. J., Bernard, K., Conklin, R., Singh, S., Frye, J. B., Madhavan, L., Doyle, K. R., Sherman, S. J., Steece-Collier, K., & Falk, T. (2026). Neuroprotective activity of sub-anesthetic ketamine in a preclinical model of Parkinson’s disease is not blocked by antagonizing brain-derived neurotrophic factor signaling. https://doi.org/10.64898/2026.10.28.762430

Source records